Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04875208 · ClinicalTrials.gov registry record

Seguimos Avanzando - Latino Youth Coping With Discrimination

A clinical trial of Mental Health, sponsored by Massachusetts General Hospital.

Completed
Registry status
886
Enrollment target
1
Study location

NCT04875208: Completed study of Mental Health, sponsored by Massachusetts General Hospital.

NCT04875208 is a study of Mental Health that has completed, run by Massachusetts General Hospital. The registered enrollment target is 886 participants, below the 10,169-participant average among 62 other Mental Health trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04875208, a study of Mental Health, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
886 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this study is to investigate mediators and moderators at multiple ecological (individual, family/peer and school/neighborhood levels) and time-scale (micro- and macro-time) levels in the link between discrimination-related stressors and mental health among 340 Mexican-origin youth.

Primary Outcome

Youth Depression, Total score 0-24, Higher scores are worse

Conditions Studied

Study Locations (1)

Indiana

  • University of Notre Dame, William J. Shaw Center for Children and Families - South Bend

Trial Details

FieldValue
Enrollment Target 886 participants
Start Date 2021-04-09
Est. Completion 2024-10-11
Massachusetts General Hospital

2,032 total trials

What the finished NCT04875208 record still lists

NCT04875208 is an observational study that tracks outcomes without assigning an intervention. The registered 886 participants enrollment target is mid-sized for trials with a published cap, below the 10,169-participant average among 62 other Mental Health trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Mental Health appearing as the primary indexed condition, and to 0 interventions.

NCT04875208 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT04875208 about?

NCT04875208 is a clinical study titled "Seguimos Avanzando - Latino Youth Coping With Discrimination". The overall objective of this study is to investigate mediators and moderators at multiple ecological (individual, family/peer and school/neighborhood levels) and time-scale (micro- and macro-time) levels in the link between discrimination-related stressors and mental health among 340 Mexican-origin...

What is the current status of trial NCT04875208?

This trial is currently completed. The enrollment target is 886 participants. The study started on 2021-04-09. Estimated completion is 2024-10-11.

What conditions does trial NCT04875208 study?

This clinical trial studies the following conditions: Mental Health.

Who is sponsoring clinical trial NCT04875208?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04875208 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mental Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04875208's enrollment target sits among peer trials

886 17th of 62 higher than 46 of 62 other Mental Health trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mental Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03564340 · 890 participants · Phase 1

    Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

  • NCT07196748 · 882 participants · Phase 3

    A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  • NCT05855200 · 892 participants · Phase 3

    Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

  • NCT05174286 · 880 participants · NA

    Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04875208, the US trial registry maintained by the National Library of Medicine. NCT04875208 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.